Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer

Journal of Molecular Graphics and Modelling

Volumn 60, Issue , 2015, Pages 34-42

  Bellini, Reinaldo G ^a   Guimarães, Ana P ^b   Pacheco, Marco A C ^a   Dias, Douglas M ^a   Furtado, Vanessa R ^c   De Alencastro, Ricardo B ^c   Horta, Bruno A C ^c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Computer simulation; Dendrimer; Drug delivery; Molecular dynamics; PAMAM; Rifampicin

Indexed keywords

COMPUTER SIMULATION; DENDRIMERS; DRUG DELIVERY; MOLECULES; PH; TUBES (COMPONENTS);

DRUG DELIVERY SYSTEM; MOLECULAR DYNAMICS SIMULATIONS; PAMAM; PAMAM DENDRIMER; PH-DEPENDENT RELEASE; PHYSIOLOGICAL PH; POLY(AMIDO AMINE); RIFAMPICIN;

MOLECULAR DYNAMICS;

DENDRIMER; POLYAMIDOAMINE; RIFAMPICIN; SOLVENT; DRUG CARRIER; PAMAM STARBURST; POLYAMINE; TUBERCULOSTATIC AGENT; WATER;

ALGORITHM; ARTICLE; COMPLEX FORMATION; DRUG STABILITY; ENCAPSULATION; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MYCOBACTERIUM; NONHUMAN; PH; PRIORITY JOURNAL; PROTON TRANSPORT; STOICHIOMETRY; SUSTAINED DRUG RELEASE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR DOCKING; SOLUBILITY;

MYCOBACTERIUM;

ANTITUBERCULAR AGENTS; DENDRIMERS; DRUG CARRIERS; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; POLYAMINES; RIFAMPIN; SOLUBILITY; WATER;

EID: 84935923547     PISSN: 10933263     EISSN: 18734243     Source Type: Journal    
DOI: 10.1016/j.jmgm.2015.05.012     Document Type: Article

References (104)

1. A. Pawlowski, M. Jansson, M. Sköld, M.E. Rottenberg, and G. Källenius Tuberculosis and HIV co-infection PLOS Pathog. 8 2012 e1002464/1-e1002464/7
2. Global Tuberculosis Report 2013 WHO Press, World Health Organization Geneva, Switzerland Available at: http://www.who.int/tb/publications/global-report/en/
3. H.M. Blumberg, W.J. Burman, R.E. Chaisson, C.L. Daley, S.C. Etkind, L.N. Friedman, P. Fujiwara, M. Grzemska, P.C. Hopewell, M.D. Iseman, R.M. Jasmer, V. Koppaka, R.I. Menzies, R.J. O'Brien, R.R. Reves, L.B. Reichman, P.M. Simone, J.R. Starke, and A.A. Vernon Treatment of tuberculosis Am. J. Respir. Crit. Care Med. 167 2003 603 662
4. P. Blasi, A. Schoubben, S. Giovagnoli, C. Rossi, and M. Ricci Fighting tuberculosis: old drugs, new formulations Expert Opin. Drug Deliv. 6 2009 977 993
5. W.J. Burman, K. Gallicano, and C. Peloquin Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials Clin. Pharmacokinet. 40 2001 327 341
6. W.A. Petri Jr. Antimicrobial agents: drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex disease, and leprosy J.G. Hardman, L.E. Limbird, Goodman, Gilman's: The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York 1273 1294
7. B. Blomberg, S. Spinaci, B. Fourie, and R. Laing The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis Bull. World Health Organ. 79 2001 61 79
8. N. Lounis, and G. Roscigno In vitro and in vivo activities of new rifamycin derivativesagainst mycobacterial infections Curr. Pharm. Des. 10 2004 3229 3238
9. E. Maretti, T. Rossi, M. Bondi, M.A. Croce, M. Hanuskova, E. Leo, F. Sacchetti, and V. Iannuccelli Inhaled solid lipid microparticles to target alveolar macrophages for tuberculosis Int. J. Pharm. 462 2014 74 82
10. S. Agrawal, and R. Panchagnula Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms Biopharm. Drug Dispos. 26 2004 321 334
11. S. Agrawal, I. Singh, K.J. Kaur, S. Bhade, C.L. Kaul, and R. Panchagnula Bioequivalence trials of rifampicin containing formulations: extrinsic and intrinsic factors in the absorption of rifampicin. Pharm. Res. 50 2004 317 327
12. A. Sosnik, A.M. Carcaboso, R.J. Glisoni, M.A. Moretton, and D.A. Chiappetta New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery Adv. Drug Deliv. Rev. 62 2010 547 559
13. G.M. Sorokoumova, V.V. Vostrikov, A.A. Selishcheva, E.A. Rogozhkina, T.Yu. Shvets Kalashnikova, V.I. Golyshevskaya, V.I. Martynova, and L.P. Erokhin Bacteriostatic activity and decomposition products of rifampicin in aqueous solution and liposomal composition Pharm. Chem. J. 42 2008 475 478
14. C. Becker, J.B. Dressman, H.E. Junginger, S. Kopp, K.K. Midha, V.P. Shah, S. Stavchansky, and D.M. Barends Biowaiver monographs for immediate release solid oral dosage forms: rifampicin J. Pharm. Sci. 98 2009 2252 2267
15. Qurrat-Ul-Ain, S. Sharma, G.K. Khuller, and S.K. Garg Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects J. Antimicrob. Chemother. 51 2003 931 938
16. N. Duran, M.A. Alvarenga, E.C. Silva, P.S. Melo, and P.D. Marcato Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Arch. Pharm. Res. 31 2008 1509 1516
17. M.L. Manca, G. Loy, M. Zaru, A.M. Fadda, and S.G. Antimisiaris Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles Colloids Surf. B 67 2008 166 170
18. K.N.A. Kumar, S.B. Ray, and V. Nagaraja Encapsulation and release of rifampicin using poly(vinyl pyrrolidone)-poly(methacrylic acid) polyelectrolyte capsules Mater. Sci. Eng. C 29 2009 2508 2513
19. K. Hirota, T. Hasegawa, T. Nakajima, H. Inagawa, C. Kohchi, G. Soma, K. Makino, and H. Terada Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis J. Control. Release 142 2010 339 346
20. I.I. Krasnyuk Jr. Effects of solid dispersions on the solubility of antibiotics Pharm. Chem. J. 43 2009 226 229
21. P.K. Gaur, S. Mishra, V.B. Gupta, M.S. Rathod, S. Purohit, and B.A. Savla In-situ formation of liposome of rifampicin: better availability for better treatment Curr. Drug Deliv. 6 2009 461 468
22. M.L. Manca, C. Sinico, A.M. Maccioni, O. Diez, A.M. Fadda, and M. Manconi Composition influence on pulmonary delivery of rifampicin liposomes Pharmaceutics 4 2012 590 606
23. S.K. Mehta, K.K. Bhasin, N. Mehta, and S. Dham Behavior of rifampicin in association with β-cyclodextrin in aqueous media: a spectroscopic and conductometric study Colloid Polym. Sci. 283 2005 532 538
24. J.S. Patil, and S. Suresh Physicochemical characterization, in vitro release and permeation studies of respirable rifampicin-cyclodextrin inclusion complexes Indian J. Pharm. Sci. 71 2009 638 643
25. P.V. Kumar, A. Asthana, T. Dutta, and N.K. Jain Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers J. Drug Target. 14 2006 546 556
26. G.M. Dykes Dendrimers: a review of their appeal and applications J. Chem. Technol. Biotechnol. 76 2001 903 918
27. Z. Yang, B. Xu, J. He, L. Xue, Q. Guo, H. Xia, and W. Tian Solution-processable and thermal-stable triphenylamine-based dendrimers with truxene cores as hole-transporting materials for organic light-emitting devices Org. Electron. 10 2009 954 959
28. E. Bustos, and L.A. Godinez Modified surfaces with nano-structured composites of Prussian blue and dendrimers. New materials for advanced electrochemical applications Int. J. Electrochem. Sci. 6 2011 1 36
29. D. Tuerp, N. Thi-Thanh-Tam, M. Baumgarten, and K. Muellen Uniquely versatile: nano-site defined materials based on polyphenylene dendrimers New J. Chem. 36 2012 282 298
30. Z. Shi, S. Hau, J. Luo, T.-D. Kim, N.M. Tucker, J.-W. Ka, H. Sun, A. Pyajt, L. Dalton, A. Chen, and A.K.Y. Jen Highly efficient Diels-Alder crosslinkable electro-optic dendrimers for electric-field sensors Adv. Funct. Mater. 17 2007 2557 2563
31. M.R. Harpham, O. Suezer, C.-Q. Ma, P. Baeuerle, and T. Goodson Thiophene dendrimers as entangled photon sensor materials J. Am. Chem. Soc. 131 2009 973 979
32. A.-M. Caminade, B. Delavaux-Nicot, R. Laurent, and J.-P. Majoral Sensitive sensors based on phosphorus dendrimers Curr. Org. Chem. 14 2010 500 515
33. J. Guerra, M. Antonia Herrero, B. Carrion, F.C. Perez-Martinez, M. Lucio, N. Rubio, M. Meneghetti, M. Prato, V. Cena, and E. Vazquez Carbon nanohorns functionalized with polyamidoamine dendrimers as efficient biocarrier materials for gene therapy Carbon 50 2012 2832 2844
34. Z. Cheng, D.L.J. Thorek, and A. Tsourkas Porous polymersomes with encapsulated Gd-labeled dendrimers as highly efficient MRI contrast agents Adv. Funct. Mater. 19 2009 3753 3759
35. W.C. Floyd, P.J. Klemm III, D.E. Smiles, A.C. Kohlgruber, V.C. Pierre, J.L. Mynar, J.M.J. Frechet, and K.N. Raymond Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity J. Am. Chem. Soc. 133 2011 2390 2393
36. D.K. Keum, K. Naka, and Y. Chujo Effect of anionic polyamidoamine dendrimers on the crystallization of calcium carbonate by delayed addition method Bull. Chem. Soc. Jpn. 76 2003 1687 1691
37. S.-J. Yan, Z.-H. Zhou, F. Zhang, S.-P. Yang, L.-Z. Yang, and X.-B. Yu Effect of anionic PAMAM with amido groups starburst dendrimers on the crystallization of Ca-10(PO4)(6)(OH)(2)) by hydrothermal method Mater. Chem. Phys. 99 2006 164 169
38. A. Mahajan, S.R. Chhabra, and W.C. Chan Resin-bound dendrimers as high loading supports for solid phase chemistry Tetrahedron Lett. 40 1999 4909 4912
39. G. Zaupa, L.J. Prins, and P. Scrimin Resin-supported catalytic dendrimers as multivalent artificial metallonucleases Bioorg. Med. Chem. Lett. 19 2009 3816 3820
40. M.P. Kapoor, H. Kuroda, M. Yanagi, H. Nanbu, and L.R. Juneja Catalysis by mesoporous dendrimers Top. Catal. 52 2009 634 642
41. D. Astruc Palladium catalysis using dendrimers: molecular catalysts versus nanoparticles Tetrahedron Asymmetry 21 2010 1041 1054
42. D. Astruc Electron-transfer processes in dendrimers and their implication in biology, catalysis, sensing and nanotechnology Nat. Chem. 4 2012 255 267
43. K. Borowska, B. Laskowska, A. Magon, B. Mysliwiec, M. Pyda, and S. Wolowiec PAMAM dendrimers as solubilizers and hosts for 8-methoxypsoralene enabling transdermal diffusion of the guest Int. J. Pharm. 398 2010 185 189
44. S. Svenson, and D.A. Tomalia Dendrimers in biomedical applications reflections on the field Adv. Drug Deliv. Rev. 57 2005 2106 2129
45. B. Devarakonda, R.A. Hill, W. Liebenberg, M. Brits, and M.M. de Villiers Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins Int. J. Pharm. 304 2005 193 209
46. S. Svenson, and A.S. Chauhan Dendrimers for enhanced drug solubilization Nanomedicine 3 2008 679 702
47. S. Svenson Dendrimers as versatile platform in drug delivery applications Eur. J. Pharm. Biopharm. 71 2009 445 462
48. J. Hu, Y. Su, H. Zhang, T. Xu, and Y. Cheng Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery Biomaterials 32 2011 9950 9959
49. J. Lim, and E.E. Simanek Triazine dendrimers as drug delivery systems: from synthesis to therapy Adv. Drug Deliv. Rev. 64 2012 826 835
50. J. Liu, W.D. Gray, M.E. Davis, and Y. Luo Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review Interface Focus 2 2012 307 324
51. S. Sadekar, and H. Ghandehari Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery Adv. Drug Deliv. Rev. 64 2012 571 588
52. A. Vergara-Jaque, J. Comer, L. Monsalve, F.D. González-Nilo, and C. Sandoval Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM J. Phys. Chem. B 117 2013 6801 6813
53. R. Esfand, and D.A. Tomalia Poly(amidoamine) (PAMMAM) dendrimers: from biomimicry to drug delivery and biomedical applications Drug Discov. Today 6 2001 427 436
54. S. Hong, A.U. Bielinska, A. Mecke, B. Keszler, J.L. Beals, X. Shi, L. Balogh, B.G. Orr, J.R. Baker Jr., and M.M. Banaszak Holl Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport Bioconjug. Chem. 15 2004 774 782
55. I. Tanis, and K. Karatasos Association of a weakly acidic anti-inflammatory drug (ibuprofen) with a poly(amidoamine) dendrimer as studied by molecular dynamics simulations J. Phys. Chem. B 113 2009 10984 10993
56. A. Åkesson, T.K. Lind, R. Barker, A. Hughes, and M. Cárdenas Unraveling dendrimer translocation across cell membrane mimics Langmuir 28 2012 13025 13033
57. J. Caballero, H. Poblete, C. Navarro, and J.H. Alzate-Morales Association of nicotinic acid with a poly(amidoamine) dendrimer studied by molecular dynamics simulations J. Mol. Graph. Model. 39 2013 71 78
58. D.A. Tomalia, A.M. Naylor, and W.A. Goddard III Starburst dendrimers: molecular-Level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter Angew. Chem. Int. Ed. 29 2003 138 175
59. S.-T. Lin, P.K. Maiti, and W.A. Goddard III Dynamics and thermodynamics of water in PAMAM dendrimers at subnanosecond time scales J. Phys. Chem. 109 2005 8663 8672
60. W.-D. Tian, and Y.-Q. Ma Molecular dynamics simulations of a charged dendrimer in multivalent salt solution J. Phys. Chem. B 113 2009 13161 13170
61. P.K. Maiti, Y. Li, T. Cagin, and W.A. Goddard III Structure of polyamidoamide dendrimers up to limiting generations: a mesoscale description J. Chem. Phys. 130 2009 144902/1-144902/10
62. J. Aumanen, T. Kesti, V. Sundström, G. Teobaldi, F. Zerbetto, N. Werner, G. Richardt, J. van Heyst, F. Vögtle, and J. Korppi-Tommola Internal dynamics and energy transfer in dansylated POPAM dendrimers and their eosin complexes J. Phys. Chem. B 114 2010 1548 1558
63. Y. Li, and T. Hou Computational simulation of drug delivery at molecular level Curr. Med. Chem. 17 2010 4482 4491
64. W.-D. Tian, and Y.-Q. Ma Insights into the endosomal escape mechanism via investigation of dendrimer membrane interactions Soft Matter 8 2012 6378 6384
65. B. Nandy, P.K. Maiti, and A. Bunker Force biased molecular dynamics simulation study of effect of dendrimer generation on interaction with DNA J. Chem. Theory Comput. 9 2012 722 729
66. W.-d. Tian, and Y.-q. Ma Theoretical and computational studies of dendrimers as delivery vectors Chem. Soc. Rev. 42 2013 705 727
67. M. Mills, B.G. Orr, M.M.B. Holl, and I. Andricioaei Attractive hydration forces in DNA-dendrimer interactions on the nanometer scale J. Phys. Chem. B 117 2013 973 981
68. M.P. Allen, and D.J. Tildesley Computer Simulation of Liquids 1987 Oxford University Press New York, USA
69. W.F. van Gunsteren, and H.J.C. Berendsen Computer simulation of molecular dynamics: methodology, applications and perspectives in chemistry Angew. Chem. Int. Ed. 29 1990 992 1023
70. W.F. van Gunsteren, D. Bakowies, R. Baron, I. Chandrasekhar, M. Christen, X. Daura, P. Gee, D.P. Geerke, A. Glättli, P.H. Hünenberger, M.A. Kastenholz, C. Oostenbrink, M. Schenk, D. Trzesniak, N.F.A. van der Vegt, and H.B. Yu Biomolecular modelling: goals, problems, perspectives Angew. Chem. Int. Ed. 45 2006 4064 4092
71. H.J.C. Berendsen Simulating the Physical World 2007 Cambridge University Press Cambridge, UK
72. V. Maingi, M.V.S. Kumar, and P.K. Maiti PAMAM dendrimer-drug interactions: effect of ph on the binding and release pattern J. Phys. Chem. B 116 2012 4370 4376
73. V. Jain, V. Maingi, P.K. Maiti, and P.V. Bharatam Molecular dynamics simulations of PPI dendrimer-drug complexes Soft Matter 9 2013 6482 6496
74. P.A. Barra, L.F. Barraza, V.A. Jiménez, J.A. Gavin, and J.B. Alderete Drug-dendrimer supramolecular complexation studied from molecular dynamics simulations and NMR spectroscopy Struct. Chem. 25 2014 1443 1455
75. V. Law, C. Knox, Y. Djoumbou, T. Jewison, A.C. Guo, Y. Liu, A. Maciejewski, D. Arndt, M. Wilson, V. Neveu, A. Tang, G. Gabriel, C. Ly, S. Adamjee, Z.T. Dame, B. Han, Y. Zhou, and D.S. Wishart DrugBank 4.0: shedding new light on drug metabolism Nucleic Acids Res. 42 2014 D1091 D1097
76. C.S. de Magalhães, H.J.C. Barbosa, and L.E. Dardenne A genetic algorithm for the ligand-protein docking problem Genet. Mol. Biol. 4 2004 605 610
77. S.F. Sousa, P.A. Fernandes, and M.J. Ramos Protein-ligand docking: current status and future challenges Proteins Struct. Funct. Bioinf. 65 2006 15 26
78. Z. Zsoldos, D. Reid, A. Simon, S.B. Sadjad, and A.P. Johnson eHiTS: a new fast, exhaustive flexible ligand docking system J. Mol. Graph. Model. 26 2007 198 212
79. S.-Y. Huang, and X. Zou Advances and challenges in protein-ligand docking Int. J. Mol. Sci. 11 2010 3016 3034
80. S.L. Mayo, B.D. Olafson, and W.A. Goddard III DREIDING: a generic force field for molecular simulation J. Phys. Chem. 94 1990 8897 8909
81. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery Jr., T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. DAnnenber, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, and J.A. Pople Gaussian 03, Revision D.0 2004 Gaussian, Inc. Wallingford, CT
82. H.J.C. Berendsen, D. van der Spoel, and R. van Drunen GROMACS: a message-passing parallel molecular dynamics implementation Comput. Phys. Commun. 91 1995 43 56
83. E. Lindahl, B. Hess, and D. van der Spoel GROMACS 3.0: a package for molecular simulation and trajectory analysis J. Mol. Model. 7 2001 306 317
84. D. van der Spoel, E. Lindahl, B. Hess, G. Groenhof, A.E. Mark, and H.J.C. Berendsen GROMACS: fast, flexible, and free J. Comput. Chem. 26 2005 1701 1718
85. B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation J. Chem. Theory Comput. 4 2008 435 447
86. W.L. Jorgensen, D.S. Maxwell, and J. Tirado-Rives Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids J. Am. Chem. Soc. 118 1996 11225 11236
87. G.A. Kaminski, R.A. Friesner, J. Tirado-Rives, and W.L. Jorgensen Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides J. Phys. Chem. B 105 2001 6474 6487
88. W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 79 1983 926 935
89. R.W. Hockney The potential calculation and some applications Methods Comput. Phys. 9 1970 135 211
90. B. Hess, H. Bekker, H.J.C. Berendsen, and J.G.E.M. Fraaije LINCS: a linear constraint solver for molecular simulations J. Comput. Chem. 18 1997 1463 1472
91. H.J.C. Berendsen, J.P.M. Postma, W.F. van Gunsteren, A. di Nola, and J.R. Haak Molecular dynamics with coupling to an external bath J. Chem. Phys. 81 1984 3684 3690
92. U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen A smooth particle mesh Ewald method J. Chem. Phys. 103 1995 8577 8593
93. HyperChem(TM) Professional 7.51, Hypercube, Inc., 1115 NW 4th Street, Gainesville, Florida 32601, USA. Available at: http://www.hyper.com.
94. D. Cakara, J. Kleimann, and M. Borkovec Microscopic protonation equilibria of poly(amidoamine) dendrimers from macroscopic titrations Macromolecules 36 2003 4201 4207
95. A.A.S.T. Ribeiro, B.A.C. Horta, and R.B. de Alencastro MKTOP: a program for automatic construction of molecular topologies J. Braz. Chem. Soc. 19 2008 1433 1435
96. R.H. Henchman, and J.W. Essex Generation of OPLS-like charges from molecular electrostatic potential using restraints J. Comput. Chem. 20 1999 398 483
97. B.V. Manalan, P. Kolavennu, A.E. Prabahar, R.R. Nadendla, and K. Manukonda Dendritic nanoparticulated carriers for the delivery of anti tuberculosis bioactives Int. J. Biol. Pharm. Res. 5 2014 913 920
98. P. Kolhe, E. Misra, R.M. Kannan, S. Kannan, and M. Lieh-Lai Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers Int. J. Pharm. 259 2003 143 160
99. N.R. Voss, and M. Gerstein 3V: cavity, channel and cleft volume calculator and extractor Nucleic Acids Res. 38 2010 W555 W562
100. G. Pistolis, A. Malliaris, D. Tsiourvas, and C.M. Paleos Poly(propyleneimine) dendrimers as pH-sensitive controlled-release systems Chem. Eur. J. 5 1999 1440 1444
101. B. Devarakonda, D.P. Otto, A. Judefeind, R.A. Hill, and M.M. de Villiers Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes Int. J. Pharm. 345 2007 142 153
102. R.K. Tekade, T. Dutta, V. Gajbhiye, and N.K. Jain Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics J. Microencapsul. 26 2009 287 296
103. M. Nasr, M. Najlah, A. D'Emanuele, and A. Elhissi PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization Int. J. Pharm. 461 2014 242 250
104. Z. Dong, K.A. Hamid, Y. Gao, Lin.Y. Katsumi, H. Sakane, and T. Yamamoto Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats J. Pharm. Sci. 100 2011 1866 1878